Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: Application to therapeutic drug monitoring

被引:47
作者
Matar, Kamal M. [1 ]
机构
[1] Kuwait Univ, Dept Appl Therapeut, Fac Pharm, Safat, Kuwait
关键词
LC-MS-MS; Levetiracetam; Therapeutic drug monitoring;
D O I
10.1016/j.jpba.2008.05.035
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid, selective, reliable, precise, accurate, and reproducible tandem mass spectrometric (MS-MS) method for the quantification of levetiracetam (LEV) in human plasma using adenosine as an internal standard (IS) has been developed and validated. The drug and IS were extracted by solid phase extraction (SPE) technique and analyzed on Symmetry (R) C-18 column (5 mu m, 3.9 mm x 50 mm) using a mobile phase of methanol-water-formic acid (97:03:0.25, v/v/v) at a flow rate of 0.2 ml/min. Quantitation was achieved using a positive electrospray ionization (ESI+) interface employing multiple reaction monitoring (MRM) mode at MRM transitions m/z 171 > 126 and m/z 268 > 136 for LEV and IS, respectively. The method was validated over the concentration range of 1.0-40 mu g/ml (r > 0.99) with a limit of quantification of 1.0 mu g/ml (R.S.D.%; 4.1 and Bias; -9.0 to + 11.0%). Intra- and inter-run precision of LEV assay at three concentrations ranged from 0.6 to 8.9% with accuracy (bias) varied from -4.0 to 8.6% indicating good precision and accuracy. Analytical recoveries of LEV and IS from spiked human plasma were in the range of 91.7-93.4% and 80.2-84.1%, respectively. Stability of LEV in human plasma samples at different conditions showed that the drug was stable under the studied conditions. Matrix effect study showed a lack of matrix effect on mass ions of LEV and IS. The described method compared well with the commercial HPLC-UV method of Chromsystem (r(2) = 0.99). The suitability of the developed method for therapeutic drug monitoring was demonstrated by measuring LEV in human plasma samples of epileptic patients treated with LEV. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:822 / 828
页数:7
相关论文
共 22 条
[1]   Ion suppression in mass spectrometry [J].
Annesley, TM .
CLINICAL CHEMISTRY, 2003, 49 (07) :1041-1044
[2]   Pharmacokinetics and metabolism of 14C-levetiracetam, a new antlepileptic agent, in healthy volunteers [J].
Benedetti, MS ;
Whomsley, R ;
Nicolas, JM ;
Young, C ;
Baltes, E .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 59 (8-9) :621-630
[3]   Levetiracetam for partial seizures - Results of a double-blind, randomized clinical trial [J].
Cereghino, JJ ;
Biton, V ;
Abou-Khalil, B ;
Dreifuss, F ;
Gauer, LJ ;
Leppik, I .
NEUROLOGY, 2000, 55 (02) :236-242
[4]   Determination of levetiracetam in human plasma/serum/saliva by liquid chromatography-electro spray tandem mass spectrometry [J].
Guo, Tiedong ;
Oswald, Lisa M. ;
Mendu, Damodara Rao ;
Soldin, Steven J. .
CLINICA CHIMICA ACTA, 2007, 375 (1-2) :115-118
[5]   Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detection [J].
Isoherranen, N ;
Roeder, M ;
Soback, S ;
Yagen, B ;
Schurig, V ;
Bialer, M .
JOURNAL OF CHROMATOGRAPHY B, 2000, 745 (02) :325-332
[6]   Determination of levetiracetam in human plasma by liquid chromatography/electrospray tandem mass spectrometry and its application to bioequivalence studies [J].
Jain, Deepak S. ;
Subbaiah, Gunta ;
Sanyal, Mallika ;
Pal, Usha ;
Shrivastav, Pranav S. .
RAPID COMMUNICATIONS IN MASS SPECTROMETRY, 2006, 20 (17) :2539-2547
[7]   Drug monitoring and toxicology: A procedure for the monitoring of levetiracetam and zonisamide by HPLC-UV [J].
Juenke, JM ;
Brown, PI ;
Urry, FM ;
McMillin, GA .
JOURNAL OF ANALYTICAL TOXICOLOGY, 2006, 30 (01) :27-30
[8]   Mechanistic investigation of ionization suppression in electrospray ionization [J].
King, R ;
Bonfiglio, R ;
Fernandez-Metzler, C ;
Miller-Stein, C ;
Olah, T .
JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY, 2000, 11 (11) :942-950
[9]   The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam [J].
Lynch, BA ;
Lambeng, N ;
Nocka, K ;
Kensel-Hammes, P ;
Bajjalieh, SM ;
Matagne, A ;
Fuks, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (26) :9861-9866
[10]   Determination of levetiracetam in human plasma with minimal sample pretreatment [J].
Martens-Lobenhoffer, J ;
Bode-Böger, SM .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2005, 819 (01) :197-200